Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue Recognition - Summary of Sales from Contracts with Customers Disaggregated by Business Segment and Geography

The following tables present the Company’s revenue disaggregated by business segment and geography, based on management’s assessment of available data:

	Three Months Ended June 30, 2022							Three Months Ended June 30, 2021
	U.S.		Outside U.S.		Total Revenues		% of Total Revenues	U.S.		Outside U.S.		Total Revenues		% of Total Revenues
Radiochemical Products	$	1,266,249	$	113,790	$	1,380,039	57%	$	1,091,114	$	137,095	$	1,228,209	45%
Cobalt Products		89,946		9,200		99,146	4%		562,744		14,250		576,994	21%
Nuclear Medicine Products		744,154		211,469		955,623	39%		768,349		186,344		954,693	34%
Fluorine Products		—		—		—	0%		—		—		—	0%
	$	2,100,349	$	334,459	$	2,434,808	100%	$	2,422,207	$	337,689	$	2,759,896	100%

	Six Months Ended June 30, 2022							Six Months Ended June 30, 2021
	U.S.		Outside U.S.		Total Revenues		% of Total Revenues	U.S.		Outside U.S.		Total Revenues		% of Total Revenues
Radiochemical Products	$	2,776,571	$	229,391	$	3,005,962	57%	$	1,637,924	$	251,462	$	1,889,386	40%
Cobalt Products		256,502		14,550		271,052	5%		676,023		19,344		695,367	15%
Nuclear Medicine Products		1,584,536		380,699		1,965,235	38%		1,712,205		433,437		2,145,642	45%
Fluorine Products		—		—		—	0%		22,013		—		22,013	0%
	$	4,617,609	$	624,640	$	5,242,249	100%	$	4,048,165	$	704,243	$	4,752,408	100%